Advanced and Innovative Solutions to Improve Public Health - Broad Agency Announcement

The Centers for Disease Control and Prevention (CDC), the Office of the Associate Director for Science (OADS) issues this Broad Agency Announcement (BAA) for the Fiscal Year 2016 under the provisions of FAR 35.016 and FAR 6.102(d)(2) which provides for the competitive selection of research proposals. Contracts that are awarded based on responses to this BAA are as a result of full and open competition and therefore in full compliance with the provisions of PL 98-369, "The Competition in Contracting Act of 1984." CDC contracts with educational institutions, nonprofit organizations, state and local government, and private industry for research and development (R&D) in those areas covered in Part II of this BAA. The government reserves the right to make multiple awards under this announcement. This BAA establishes a four-step process for offerors contemplating submission of a proposal under this BAA. This sequence allows for an early determination of the potential for interest based on technical merit, applicability to CDC and projected funding. This process is designed to limit offeror and Government expenditure of effort to prepare and review formal proposals for research that may have little chance of being supported. Funding of research within CDC will be determined by funding availability and the following broad research priorities: 1: Commodity and temperature-sensitive biologics transportation optimization. 2: Monitoring and evaluation of contraception access in Puerto Rico. 3: Cohort studies to understand the developmental functioning impact of Zika virus on children born to women during Zika virus outbreaks. 4: Early Identification of Fetal Infection with Zika virus. 5: Prenatal Diagnostic Test Performance. 6: Improving access to clinical services for the management of Zika virus infection in pregnancy and congenital Zika virus infection. 7: Sentinel surveillance for Zika virus infection in endemic and outbreak countries and establishing a diagnostic evaluation platform. 8: Ecological Study (non-human primates and mosquitoes) on Zika Virus in countries affected by the 2016 Zika outbreak in the Americas. 9: Specimen collection and transport, logistics and inventory management and laboratory diagnostics for Zika virus. 10: Enhanced surveillance, case investigation, and cohort studies of pregnancy and infant outcomes and other population health outcomes associated with the Zika virus in countries affected by the 2016 Zika virus outbreak. For further questions, please contact the technical point of contact for each of the above areas of interest. These points of contact are contained within the attached document detailing this announcement in full.